GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cipher Pharmaceuticals Inc (TSX:CPH) » Definitions » Pretax Margin %

Cipher Pharmaceuticals (TSX:CPH) Pretax Margin % : 50.58% (As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Cipher Pharmaceuticals Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Cipher Pharmaceuticals's Pre-Tax Income for the three months ended in Mar. 2024 was C$4.02 Mil. Cipher Pharmaceuticals's Revenue for the three months ended in Mar. 2024 was C$7.94 Mil. Therefore, Cipher Pharmaceuticals's pretax margin for the quarter that ended in Mar. 2024 was 50.58%.

The historical rank and industry rank for Cipher Pharmaceuticals's Pretax Margin % or its related term are showing as below:

TSX:CPH' s Pretax Margin % Range Over the Past 10 Years
Min: -3.33   Med: 32.67   Max: 62.94
Current: 58.4


TSX:CPH's Pretax Margin % is ranked better than
98.43% of 1020 companies
in the Drug Manufacturers industry
Industry Median: 4.12 vs TSX:CPH: 58.40

Cipher Pharmaceuticals Pretax Margin % Historical Data

The historical data trend for Cipher Pharmaceuticals's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cipher Pharmaceuticals Pretax Margin % Chart

Cipher Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.43 30.25 50.40 55.52 59.92

Cipher Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 55.41 59.95 51.44 74.81 50.58

Competitive Comparison of Cipher Pharmaceuticals's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Cipher Pharmaceuticals's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cipher Pharmaceuticals's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cipher Pharmaceuticals's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Cipher Pharmaceuticals's Pretax Margin % falls into.



Cipher Pharmaceuticals Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Cipher Pharmaceuticals's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=17.013/28.391
=59.92 %

Cipher Pharmaceuticals's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=4.017/7.942
=50.58 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cipher Pharmaceuticals  (TSX:CPH) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Cipher Pharmaceuticals Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Cipher Pharmaceuticals's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cipher Pharmaceuticals (TSX:CPH) Business Description

Traded in Other Exchanges
Address
5750 Explorer Drive, Suite 404, Mississauga, ON, CAN, L4W 0A9
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products among others. The company's geographical operational areas include Canada and the United States.
Executives
Mark Beaudet Director

Cipher Pharmaceuticals (TSX:CPH) Headlines

No Headlines